EMA Authorised: Cancidas (previously Caspofungin MSD) (caspofungin (as acetate))

View source ↗

Summary

EMA has authorised Cancidas (caspofungin acetate) for the treatment of candidiasis and aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Status: Authorised. Therapeutic area: Candidiasis;Aspergillosis. Decision date: 05/01/2026